# Treatment of Chronic Laryngitis With Amitriptyline

> **NCT02552225** · PHASE2,PHASE3 · TERMINATED · sponsor: **Boston Medical Center** · enrollment: 6 (actual)

## Conditions studied

- Laryngeal Diseases

## Interventions

- **DRUG:** Amitriptyline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02552225
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04
- **Primary completion:** 2021-01-15
- **Final completion:** 2021-01-15
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Funding was not obtained so the study could not be continued after the Covid pause.
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02552225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02552225, "Treatment of Chronic Laryngitis With Amitriptyline". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02552225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*